New Zealand's diagnostic market has been experiencing rapid growth spurred by novel technologies. The integration of advanced imaging and pathology services has given tremendous impetus to the healthcare industry. Progressive developments in imaging technologies like MRI, ultrasound, and CT scan have led to the early identification of diverse health issues,...
Discover more insightsThe market for substances of misuse testing is a rapidly expanding sector primarily driven by societal, economic and regulatory factors. The increasing misuse of drugs, both legal prescription drugs and illegal substances has intensified the need for comprehensive testing protocols. Economically, this sector is supported by governments increased spending on...
Discover more insightsPoint-of-Care (POC) HbA1c testing, a rapid method to determine a person's average blood glucose concentration, is witnessing increased demand. Drivers include an upswing in the prevalence of diabetes, advancements in technology, and the need for faster diagnosis and management of the disease. These tests being less time-consuming and more patient-friendly,...
Discover more insightsThe driving forces behind the rising trends in cell-based assays are multifaceted. Foremost among these is the surge in the prevalence of chronic and genetic diseases; these conditions require advanced investigative approaches and therapies, both domains where cell-based assays are crucial. Simultaneously, the expanding biopharmaceutical and biotechnological industries globally necessitate...
Discover more insightsThe diagnostics sector is characterized by the presence of a large number of players, which range from multinational corporations to small and medium enterprises. Key international players, such as Roche, Abbott, and Siemens, not only boast a broad portfolio of diagnostic products, but also command a substantial share of the...
Discover more insightsThe biomedical diagnostics sector has been exhibiting transformative growth due to advancements in technology coupled with rising global health concerns and increased healthcare spending. It has become a complex interplay of mature technologies that continue to evolve, and new, disruptive modalities that are gaining traction. This paradoxical landscape has yielded...
Discover more insightsThe diagnostics market embodies a significant segment of the healthcare industry, comprising various technologies, devices, and methods used for identifying specific diseases or conditions. With its wide spectrum, ranging from in-vitro diagnostics (IVD) and imaging diagnostics to molecular diagnostics, this market sector supports accurate detection and timely intervention. The steady...
Discover more insightsPresently, various innovative diagnostic tools are being introduced in the field of Hepatitis. Advanced molecular technologies, such as Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Isothermal Nucleic Acid Amplification Tests (INAATs) are adding value to the market. In addition, immune-assay based techniques, including Enzyme-Linked Immunosorbent Assay (ELISA) and...
Discover more insightsThe companion diagnostics sector is experiencing substantial growth and is projected to continue on this upward trend. Numerous factors are feeding this expansion, including escalating prevalences of chronic diseases and progressive advancements in genomic science. Crucially, heightened awareness and adoption of personalized therapies are contributing significantly to increased market demand....
Discover more insightsThe healthcare sector is seeing a wave of innovation spurred by advancements in technology. Key players in the diagnostic testing sector are focusing on the development of innovative technologies, for instance, molecular diagnostics using next-generation sequencing, PCR advancements, and microarrays. Liquid biopsy is another exciting development, enabling non-invasive tests detecting...
Discover more insights